T 2506/12 of 04.10.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T250612.20161004
- Date of decision
- 4 October 2016
- Case number
- T 2506/12
- Petition for review of
- -
- Application number
- 05803151.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PEGYLATED LIPOSOMAL DOXORUBICIN IN COMBINATION WITH ECTEINESCIDIN 743
- Applicant name
- Pharma Mar S.A., Sociedad Unipersonal
Ortho Biotech Products L.P. - Opponent name
- Teva Pharmaceutical Industries Ltd.
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56
- Keywords
- Novelty - second (or further) medical use (yes)
Inventive step - reasonable expectation of success (yes) - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.